{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:52:16Z","timestamp":1793757136432,"version":"4.6.1"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Secretar\u00eda de Ciencia y T\u00e9cnica (SECyT) from Universidad Nacional de C\u00f3rdoba and from Universidad Nacional de La Rioja"},{"name":"Ministerio de Ciencia y Tecnolog\u00eda de la Provincia de C\u00f3rdoba"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.actatropica.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T13:41:14Z","timestamp":1425044474000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease"],"prefix":"10.1016","volume":"145","author":[{"given":"M. Silvina","family":"Lo Presti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Carolina","family":"Baz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra L.","family":"B\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Walter","family":"Rivarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Paglini-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.actatropica.2015.02.012_bib0005","first-page":"267","article-title":"Mechanisms by which thioridazine in combination with antibiotics cures extensively drug-resistant infections of pulmonary tuberculosis","volume":"28","author":"Amaral","year":"2014","journal-title":"In Vivo"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/138945006777709539","article-title":"\u2018Non-antibiotics\u2019: alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries","volume":"7","author":"Amaral","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"12","key":"10.1016\/j.actatropica.2015.02.012_bib0015","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1046\/j.1365-3156.2001.00804.x","article-title":"Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries","volume":"6","author":"Amaral","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0035-9203(92)90156-7","article-title":"Specific chemotherapy of Chagas\u2019 disease: a comparison between the response in patients and experimental animals infected with the same strains","volume":"86","author":"Andrade","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0025","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1179\/136485905X75403","article-title":"Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment","volume":"99","author":"Apt","year":"2005","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0030","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/2211362611208020136","article-title":"Persistence of Trypanosoma cruzi in experimental chagasic cardiomyopathy","volume":"10","author":"Baz\u00e1n","year":"2012","journal-title":"Anti-Infect. Agents"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0040","series-title":"Principles of Psychopharmacology","author":"Biel","year":"1978"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0045","series-title":"Biological and Chemical Aspects of Thiazines and Analogs. Proceedings of the Seventh International Conference on Phenothiazines and Structurally Related Psychotropic Compounds, Marseille, France, August 29th\u2013September 2nd, 1993","first-page":"433","article-title":"Resent trends in the field of calmodulin inhibitors","author":"Bondy","year":"1995"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0050","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1021\/jm000219o","article-title":"(2,2\u2032:6\u2032,2\u2033-Terpyridine) platinum (II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase","volume":"43","author":"Bonse","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1590\/S0036-46652000000300009","article-title":"Persistent infection in chronic Chagas disease patients with anti-Trypanosoma cruzi nitroderivatives","volume":"42","author":"Braga","year":"2000","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijantimicag.2007.01.014","article-title":"Treatment with benznidazole or thioridazine in the chronic phase of experimental Chagas disease improves cardiopathy","volume":"29","author":"Bustamante","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0014-4894(03)00096-1","article-title":"Trypanosoma cruzi reinfections provoke synergistic effect and cardiac \u03b2-adrenergic receptors\u2019 dysfunction in the acute phase of experimental Chagas\u2019 disease","volume":"103","author":"Bustamante","year":"2003","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/cs1040415","article-title":"Indeterminate Chagas disease: Trypanosoma cruzi strain and reinfections are factors involved in the progression of cardiopathy","volume":"104","author":"Bustamante","year":"2003","journal-title":"Clin. Sci."},{"issue":"3","key":"10.1016\/j.actatropica.2015.02.012_bib0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1586\/17512433.2014.909282","article-title":"Potential new clinical therapies for Chagas disease","volume":"7","author":"Bustamante","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02761999000700064","article-title":"Criteria of Chagas disease cure","volume":"94","author":"Can\u00e7ado","year":"1999","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0085","first-page":"19","article-title":"Toxic effects of nifurtimox and benznidazole, two drugs used against American Trypanosomiasis (Chagas\u2019 disease)","volume":"1","author":"Castro","year":"1988","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0090-1229(84)90071-0","article-title":"Experimental myocarditis induced in Swiss mice by homologous heart immunization resembles chronic experimental Chagas\u2019 heart disease","volume":"33","author":"Cossio","year":"1984","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"I","key":"10.1016\/j.actatropica.2015.02.012_bib0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed \u2013 a background article","volume":"102","author":"Coura","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0100","first-page":"30","article-title":"Tripanosomose, doen\u00e7a de Chagas","volume":"55","author":"Coura","year":"2003","journal-title":"Ci\u00eanc. Cult."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jac\/dkn217","article-title":"Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide","volume":"62","author":"Couto","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(90)90106-W","article-title":"Sensitivity of parasites to free radical damage by antiparasitic drugs","volume":"73","author":"Docampo","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0115","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0968-0896(96)00120-4","article-title":"Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors","volume":"4","author":"Faerman","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0120","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1146\/annurev.mi.46.100192.003403","article-title":"Metabolism and function of trypanothione in the Kinetoplastida","volume":"46","author":"Fairlamb","year":"1992","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0125","first-page":"179","article-title":"Future prospects for chemotherapy of Chagas\u2019 disease","volume":"59","author":"Fairlamb","year":"1999","journal-title":"Medicina (Buenos Aires)"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0130","first-page":"59","article-title":"Effects of prometazine on the viability of T. cruzi","volume":"57","author":"Fern\u00e1ndez","year":"1997","journal-title":"Medicina (Buenos Aires)"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0135","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental Chagas disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4986","key":"10.1016\/j.actatropica.2015.02.012_bib0140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons","volume":"253","author":"Ggerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/10715760100300311","article-title":"Trypanosoma cruzi trypanothione reductase is inactivated by peroxidase generated phenothiazine cationic radicals","volume":"34","author":"Gutierrez-Correa","year":"2001","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/cclm-2012-0316","article-title":"Chronic Chagas disease: from basics to laboratory medicine","volume":"51","author":"Haberland","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0155","first-page":"33","article-title":"Effect of thioridazine on experimental cutaneous staphylococcal infections","volume":"28","author":"Hahn","year":"2014","journal-title":"In Vivo"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0160","first-page":"39","article-title":"Trypanothione dependent peroxide metabolism in Crithidia fasciculata and Trypanosoma brucei","volume":"24","author":"Henderson","year":"1987","journal-title":"Mol. Biochem."},{"issue":"12","key":"10.1016\/j.actatropica.2015.02.012_bib0165","first-page":"1732","article-title":"Inhibitor of calmodulin and calmodulin dependent enzyme","volume":"43","author":"Hidaka","year":"1998","journal-title":"Tanpakushitsu Kakusan Koso"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0008-6363(03)00361-4","article-title":"Pathophysiology of the heart in Chagas\u2019 disease: current status and new developments","volume":"60","author":"Higuchi","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0175","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0022-2836(92)90701-K","article-title":"Active site of trypanothione reductase. A target for rational drug design","volume":"227","author":"Hunter","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0180","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1017\/S0031182097008962","article-title":"A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs","volume":"114","author":"Hunter","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1432-1033.1989.tb14643.x","article-title":"Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds","volume":"180","author":"Jockers-Scher\u00fcbl","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0190","first-page":"182","article-title":"A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy","volume":"105","author":"Jones","year":"1992","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0195","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/AAC.37.5.1086","article-title":"Efflux-mediated fluoroquinolones resistance in Staphylococcus aureus","volume":"37","author":"Kaatz","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0200","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/AAC.47.2.719-726.2003","article-title":"Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus","volume":"47","author":"Kaatz","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0205","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0169-4758(96)10058-2","article-title":"Autoimmunity in Chagas\u2019 cardiomiopathy: fulfilling the criteria at last","volume":"12","author":"Kalil","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0210","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1038\/277093a0","article-title":"Multiples receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0215","series-title":"Biological and Chemical Aspects of Thiazines and Analogs. Proceedings of the Seventh International Conference on Phenothiazines and Structurally Related Psychotropic Compounds, Marseille, France, August 29th\u2013September 2nd, 1993","first-page":"103","author":"Keyzer","year":"1995"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0220","series-title":"Emerging Infections 3","first-page":"111","article-title":"Chagas disease (American Trypanosomiasis): a tropical disease now emerging in the United States","author":"Kirchhoff","year":"1999"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0510","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1096\/fasebj.9.12.7672506","article-title":"Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design","volume":"9","author":"Krauth-Siegel","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0225","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1007\/s00436-002-0771-8","article-title":"Parasite-specific trypanothione reductase as a drug target molecule","volume":"90","author":"Krauth-Siegel","year":"2003","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0230","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2958.2000.01721.x","article-title":"Trypanosomes lacking trypanothione reductase are a virulent and show increased sensitivity to oxidative stress","volume":"35","author":"Krieger","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0235","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0924-8579(03)00200-0","article-title":"Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro","volume":"22","author":"Kristiansen","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0240","first-page":"361","article-title":"Thioridazine reduces resistance of methicillin-resistant Staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump","volume":"20","author":"Kristiansen","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0245","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1073\/pnas.88.19.8764","article-title":"X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution","volume":"88","author":"Kuriyan","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/prot.340180208","article-title":"The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state","volume":"18","author":"Lantwin","year":"1994","journal-title":"Proteins"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0255","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(10)70098-0","article-title":"Chagas disease: changes in knowledge and management","volume":"10","author":"Lescure","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0260","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2005.07.032","article-title":"Changes in the cardiac \u03b2-adrenergic system in the acute phase of the Trypanosoma cruzi myocardiopathy","volume":"111","author":"Lo Presti","year":"2006","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0265","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijantimicag.2003.10.006","article-title":"Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice","volume":"23","author":"Lo Presti","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0270","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.ijpara.2008.04.009","article-title":"Some components of the cardiac \u03b2-adrenergic system are altered in the chronic indeterminate form of the experimental Trypanosoma cruzi infection","volume":"38","author":"Lo Presti","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S0031182009006337","article-title":"Involvement of the \u03b2-adrenergic system in the cardiac chronic form of the experimental Trypanosoma cruzi infection","volume":"136","author":"Lo Presti","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402004118","article-title":"Chagas disease: role of parasite genetic variation in pathogenesis","volume":"4","author":"Macedo","year":"2002","journal-title":"Expert Rev. Mol. Med."},{"issue":"10","key":"10.1016\/j.actatropica.2015.02.012_bib0285","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1590\/S0102-311X2007001000002","article-title":"Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease","volume":"23","author":"Manoel-Caetano","year":"2007","journal-title":"Cad. Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0290","first-page":"274","article-title":"Enfermedad de Chagas: controversia sobre tratamiento espec\u00edfico en fases latente y cr\u00f3nica","volume":"31","author":"Manssur","year":"2002","journal-title":"Rev. Fed. Arg. Cardiol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1590\/S0074-02762009000900042","article-title":"The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease","volume":"104","author":"Marin-Neto","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2008.04.001","article-title":"Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas\u2019 cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)","volume":"156","author":"Marin-Neto","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0305","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1021\/jm050027z","article-title":"Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis","volume":"48","author":"Meiering","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0310","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0020-7519(01)00171-0","article-title":"Parasite polyclonal activators: new targets for vaccination approaches?","volume":"31","author":"Minoprio","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0315","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4269\/ajtmh.1996.55.625","article-title":"Characterization of Trypanosoma cruzi population by zymodemes: correlation with clinical picture","volume":"55","author":"Montamat","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0742-8413(88)90090-4","article-title":"The biochemistry of the mode of action of drugs and the detoxication mechanisms in Trypanosoma cruzi","volume":"90","author":"Morello","year":"1988","journal-title":"Comp. Biochem. Phys. C"},{"issue":"6","key":"10.1016\/j.actatropica.2015.02.012_bib0325","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/01.CIR.82.6.1900","article-title":"Pathophysiological insights into the cardiomyopathy of Chagas\u2019 disease","volume":"82","author":"Morris","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0330","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.37.1.128","article-title":"Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter","volume":"37","author":"Neyfakh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0335","first-page":"395","article-title":"Pharmacological and contractile response of myocardium of Chagasic Albino Swiss mice","volume":"37","author":"Paglini Oliva","year":"1987","journal-title":"Acta Physiol. Pharmacol. Latinoam."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0340","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/exmp.1998.2227","article-title":"Structural, ultrastructural studies and evolution of Trypanosoma cruzi-infected mice treated with thioridazine","volume":"65","author":"Paglini-Oliva","year":"1998","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0345","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0020-7519(01)00168-0","article-title":"The role of endothelin in the pathogenesis of Chagas\u2019 disease","volume":"31","author":"Petkova","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0350","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568026013395605","article-title":"Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance","volume":"1","author":"Poole","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0355","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/00034989957943","article-title":"Thioridazine treatment modifies the evolution of Trypanosoma cruzi infection in mice","volume":"93","author":"Rivarola","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0360","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on Chagas disease chemotherapy","volume":"97","author":"Rodrigues Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.actatropica.2015.02.012_bib0365","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/jac\/dku036","article-title":"Novel non-neuroleptic phenothiazines inhibit Mycobacterium tuberculosis replication","volume":"69","author":"Salie","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0370","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(76)90391-7","article-title":"Dopamine metabolism in the mesolimbic and mesocortical dopamine systems after single or repeated administration of neuroleptics","volume":"1108","author":"Scatton","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0074-02761994000200017","article-title":"Reversibility of muscle and heart lessions in chronic, Trypanosoma cruzi infected mice after late trypanocidal treatment","volume":"89","author":"Segura","year":"1994","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"Suppl.","key":"10.1016\/j.actatropica.2015.02.012_bib0380","first-page":"316","article-title":"Regression of antibodies and resistance to reinfection in mice inoculated with an attenuated Trypanosoma cruzi strain and treated with nifurtimox","volume":"91","author":"Segura","year":"1996","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.actatropica.2015.02.012_bib0385","first-page":"307","article-title":"Heart transplantation in patients with Chagas\u2019 disease cardiomyopathy","volume":"6","author":"Stolf","year":"1987","journal-title":"J. Heart Transplant."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0390","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1021\/bi963074p","article-title":"Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity","volume":"36","author":"Stoll","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0395","first-page":"147","article-title":"The chemotherapy of Chagas disease","volume":"59","author":"Stoppani","year":"1999","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.parint.2013.02.004","article-title":"Clomipramine and benznidazole association for the treatment of acute experimental Trypanosoma cruzi infection","volume":"62","author":"Strauss","year":"2013","journal-title":"Parasitol. Int."},{"issue":"3","key":"10.1016\/j.actatropica.2015.02.012_bib0405","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0169-4758(99)01398-8","article-title":"Chagas disease etiology: autoimmunity or parasite persistence?","volume":"5","author":"Tarleton","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0410","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0020-7519(01)00158-8","article-title":"Parasite persistence in the aetiology of Chagas disease","volume":"31","author":"Tarleton","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0415","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1590\/S0074-02762006000500001","article-title":"Evolution and pathology in Chagas disease \u2013 a review","volume":"101","author":"Teixeira","year":"2006","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.actatropica.2015.02.012_bib0420","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2125.2007.03021.x","article-title":"Thioridazine: a resurrection as an antimicrobial agent?","volume":"64","author":"Thanacoody","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.actatropica.2015.02.012_bib0425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/157489111796064588","article-title":"Thioridazine: the good and the bad","volume":"6","author":"Thanacoody","year":"2011","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"issue":"1","key":"10.1016\/j.actatropica.2015.02.012_bib0430","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0003-9861(02)00745-2","article-title":"The trypanothione-thiol system in Trypanosoma cruzi as a key antioxidant mechanism against peroxynitrite-mediated cytotoxicity","volume":"412","author":"Thomson","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.actatropica.2015.02.012_bib0435","doi-asserted-by":"crossref","first-page":"e64514","DOI":"10.1371\/journal.pone.0064518","article-title":"Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus USA300","volume":"8","author":"Thorsing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"issue":"11","key":"10.1016\/j.actatropica.2015.02.012_bib0445","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pt.2003.09.001","article-title":"Specific chemotherapy of Chagas disease: controversies and advances","volume":"19","author":"Urbina","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0450","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/AAC.01662-13","article-title":"Towards a paradigm shift in the treatment of chronic Chagas disease","volume":"58","author":"Viotti","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0455","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1586\/14787210.5.4.717","article-title":"Etiological treatment of chronic Chagas disease: neglected \u2018evidence\u2019 by evidence-based medicine","volume":"5","author":"Viotti","year":"2007","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.actatropica.2015.02.012_bib0460","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities","volume":"7","author":"Viotti","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.actatropica.2015.02.012_bib0465","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0470","first-page":"99","article-title":"New insights into Chagas\u2019 disease: a neglected disease in Latin America","volume":"1","author":"Von","year":"2007","journal-title":"J. Infect. Dev. Ctries"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.pa.35.040195.000521","article-title":"Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis","volume":"35","author":"Wang","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0480","series-title":"Control of Chagas Disease. Second Report of the WHO Expert Committee. WHO Technical Report Series, No 905","author":"WHO","year":"2002"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0485","series-title":"Report on Chagas Disease. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases","author":"WHO","year":"2007"},{"issue":"5852","key":"10.1016\/j.actatropica.2015.02.012_bib0490","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/296034a0","article-title":"A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites","volume":"296","author":"Wood","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2015.02.012_bib0495","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.clpt.6100069","article-title":"Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study","volume":"81","author":"Yang","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.actatropica.2015.02.012_bib0500","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1590\/S0074-02762003000400026","article-title":"8-Methoxy-naphtho[2,3-b]thiophen-4,9-quinone, a non-competitive inhibitor of trypanothione reductase","volume":"98","author":"Zani","year":"2003","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.actatropica.2015.02.012_bib0505","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1086\/314889","article-title":"Parasite persistence correlates with disease severity and localization in chronic Chagas\u2019 disease","volume":"180","author":"Zhang","year":"1999","journal-title":"J. Infect. Dis."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15000327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15000327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T06:51:27Z","timestamp":1598770287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X15000327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":102,"alternative-id":["S0001706X15000327"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.02.012","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}